Chemical Compound
Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2a,5ss,6a,18ss)-; Catharanthine (6CI,7CI,8CI); 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine-18-carboxylic acid deriv.; (+)-3,4-Didehydrocoronaridine; (+)-Catharanthine; Catharanthin; Catharanthine, (+)-
CAS Registry Number
2468-21-5
Primary record
Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2a,5ss,6a,18ss)-; Catharanthine (6CI,7CI,8CI); 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine-18-carboxylic acid deriv.; (+)-3,4-Didehydrocoronaridine; (+)-Catharanthine; Catharanthin; Catharanthine, (+)-
- 库存
- 6,816 克
- 纯度
- 99.2 %
- CAS
- 2468-21-5
化合物标识与属性
- CAS
- 2468-21-5
- PubChem CID
- 5458190
- SMILES
- CCC1=C[C@H]2C[C@]3([C@@H]1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC
- Canonical SMILES
- CCC1=C[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@](C(=O)OC)(C2)[C@@H]13
名称与同义词
- Catharanthine
- Catharanthin
- 2468-21-5
- (+)-Catharanthine
- Catharanthine Base
- Catharanthine tartrate
- (+)-3,4-Didehydrocoronaridine
- WT0YJV846J
- Catharanthine, (+)-
- UNII-WT0YJV846J
- RefChem:574901
- Catharanthine (free base)
- CATHARANTHINE [MI]
- CHEBI:3469
- C21H24N2O2
- CHEMBL2163793
- DTXSID80947621
- (+)-3,4-Dihydrocoronaridine
- CMKFQVZJOWHHDV-NQZBTDCJSA-N
- MFCD01753356
- SCHEMBL31474869
- EINECS 219-586-6
- Catharanthine, >=95% (HPLC)
- DTXCID401527514
- HMS2095F15
- HMS3652A13
- HMS3712F15
- HMS3885K13
- BDBM50396009
- EBC-17062
- MSK168797
- NSC823867
- s3202
- ZINC57297068
- AKOS024463388
- C21-H24-N2-O2
- ACN-056682
- CATHARANTHINE (REFERENCE GRADE)
- CCG-220187
- CID5458190
- FC10810
- NSC-823867
- AC-34053
- J15.154H
- R101
- 1013B
- FT-0623520
- FT-0776226
- NS00018340
- ST24046287
- SW198653-2
- J2.996.318E
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2alpha,5beta,6alpha,18beta)-
- Q-9249
- AB01566866_01
- 468C215
- A877834
- BRD-K92377961-001-02-9
- BRD-K92377961-001-03-7
- B0005-464321
- methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate
- Methyl (2?,5?,6?)-3,4-didehydroibogamine-18?-carboxylate
- methyl (2alpha,18beta)-3,4-didehydroibogamine-18-carboxylate
- Methyl (2alpha,5beta,6alpha)-3,4-didehydroibogamine-18beta-carboxylate
- Methyl (2-alpha,5-beta,6-alpha,18-beta)-3,4-didehydroibogamine-18-carboxylate
- (6R,6aR,9R,11R)-Methyl 7-ethyl-6,6a,9,10,12,13-hexahydro-5H-6,9-methanopyrido[1',2':1,2]azepino[4,5-b]indole-6-carboxylate
- Methyl (6R)-2alpha,5beta,18beta-3,4-didehydroibogamine-18-carboxylate
- (2-alpha,5-beta,6-alpha,18-beta)-3,4-Didehydroibogamine-18-carboxylic acid methyl ester
- (2|A,5|A,6|A,18|A)-3,4-Didehydroibogamine-18-carboxylic acid methyl ester
- [2alpha,5beta,6alpha,18beta,(+)]-3,4-Didehydroibogamine-18-carboxylic acid methyl ester
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2|A,5|A,6|A,18|A)-
- (1beta,4beta)-2,6-[Ethylene(1H-indole-3,2-diyl)]-7-ethyl-2-azabicyclo[2.2.2]octa-7-ene-6beta-carboxylic acid methyl ester
- (6R,6aR,9R,11R)-Methyl7-ethyl-6,6a,9,10,12,13-hexahydro-5H-6,9-methanopyrido[1',2':1,2]azepino[4,5-b]indole-6-carboxylate
- 219-586-6
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2-alpha,5-beta,6-alpha,18-beta)-
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2.alpha.,5.beta.,6.alpha.,18.beta.)-
- Ibogamine-18-carboxylic acid, 3,4-didehydro-, methyl ester, (2a,5ss,6a,18ss)-; Catharanthine (6CI,7CI,8CI); 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole, ibogamine-18-carboxylic acid deriv.; (+)-3,4-Didehydrocoronaridine; (+)-Catharanthine; Catharanthin; Catharanthine, (+)-
- IBOGAMINE-18-CARBOXYLIC ACID, 3,4-DIDEHYDRO-, METHYL ESTER,(2.ALPHA.,5.BETA.,6.ALPHA.,18.BETA.)-
- methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate
- methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.0^{2,10}.0^{4,9}.0^{13,18}]nonadeca-2(10),4(9),5,7,16-pentaene-1-carboxylate